Clover Health Investments (NASDAQ:CLOV) Stock Sees Unusually High Put Option Buying

Posted by George Bondi on Nov 2nd, 2026

Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) was the recipient of some unusual options trading activity on Monday. Traders acquired 22,313 put options on the stock. This is an increase of approximately 36% compared to the average daily volume of 16,415 put options.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft began coverage on Clover Health Investments in a research note on Thursday, September 10th. They set a “buy” rating and a $6.00 price target on the stock. Canaccord Genuity Group upped their price objective on shares of Clover Health Investments from $4.20 to $5.50 and gave the stock a “buy” rating in a research note on Tuesday, July 21st. UBS Group increased their target price on shares of Clover Health Investments from $4.75 to $5.00 and gave the stock a “neutral” rating in a report on Thursday, August 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of Clover Health Investments in a research report on Monday, September 21st. Finally, Wall Street Zen lowered shares of Clover Health Investments from a “strong-buy” rating to a “buy” rating in a report on Sunday, August 16th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Clover Health Investments currently has a consensus rating of “Hold” and an average price target of $5.00.

View Our Latest Research Report on Clover Health Investments

Insider Activity at Clover Health Investments

In related news, CEO Andrew Toy sold 62,176 shares of the business’s stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $4.68, for a total value of $290,983.68. Following the completion of the sale, the chief executive officer owned 9,078,334 shares in the company, valued at approximately $42,486,603.12. The trade was a 0.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Conrad Wai sold 23,627 shares of the stock in a transaction that occurred on Thursday, October 15th. The stock was sold at an average price of $4.68, for a total value of $110,574.36. Following the completion of the transaction, the chief executive officer directly owned 1,042,072 shares in the company, valued at approximately $4,876,896.96. This trade represents a 2.22% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 856,371 shares of company stock worth $3,870,740. Insiders own 23.51% of the company’s stock.

Institutional Trading of Clover Health Investments

A number of institutional investors have recently made changes to their positions in the business. Vise Technologies Inc. purchased a new position in Clover Health Investments during the 3rd quarter worth $115,000. State of Wyoming raised its stake in Clover Health Investments by 20.1% in the third quarter. State of Wyoming now owns 94,729 shares of the company’s stock valued at $408,000 after buying an additional 15,857 shares during the last quarter. Sterling Capital Management LLC raised its stake in Clover Health Investments by 847.9% in the third quarter. Sterling Capital Management LLC now owns 14,000 shares of the company’s stock valued at $60,000 after buying an additional 12,523 shares during the last quarter. Nisa Investment Advisors LLC boosted its holdings in Clover Health Investments by 223.4% in the third quarter. Nisa Investment Advisors LLC now owns 10,855 shares of the company’s stock worth $47,000 after acquiring an additional 7,498 shares in the last quarter. Finally, Ballew Advisors Inc acquired a new stake in Clover Health Investments in the third quarter worth about $44,000. Institutional investors and hedge funds own 19.77% of the company’s stock.

Clover Health Investments Stock Performance

NASDAQ:CLOV traded down $0.15 during midday trading on Monday, reaching $4.31. 5,002,921 shares of the stock traded hands, compared to its average volume of 5,806,081. Clover Health Investments has a 12-month low of $1.58 and a 12-month high of $5.59. The business has a 50-day moving average of $4.51 and a two-hundred day moving average of $3.54. The stock has a market capitalization of $2.29 billion, a PE ratio of -86.18 and a beta of 2.52.

Clover Health Investments (NASDAQ:CLOV – Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.01. Clover Health Investments had a negative net margin of 0.74% and a negative return on equity of 4.20%. The company had revenue of $743.17 million during the quarter, compared to the consensus estimate of $728.27 million. Research analysts anticipate that Clover Health Investments will post 0.06 earnings per share for the current year.

Clover Health Investments Company Profile

(Get Free Report)

Clover Health Investments, Corp. is a health insurance technology company focused on providing Medicare Advantage plans to eligible seniors in the United States. Its plans combine hospital, medical and prescription drug coverage with additional benefits that may vary by plan and location.

The company uses its Clover Assistant technology platform to provide physicians with data-driven insights intended to support clinical decision-making and care coordination. The platform aggregates member health information and helps participating providers identify care opportunities, manage chronic conditions and engage with patients.

Clover Health was founded in 2012 and became a publicly traded company in 2021 through a merger with a special purpose acquisition company.